Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05855317

Association Between the Level of EV-TF and the Occurence of Pulmonary Embolism in Patients With ARDS

Association Between the Level of Extracellular Vesicle - Associated Tissue Factor and the Occurence of Pulmonary Embolism in Patients With Acute Respiratory Distress Syndrome

Status
Recruiting
Phase
Study type
Observational
Enrollment
170 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, 120 patients with Acute Respiratory Distress Syndrome (ARDS) will be included on a two years-period in an intensive care unit (Assistance Publique des Hôpitaux de Marseille, France). Those patients will benefit from a blood test at inclusion in order to measure several coagulation biomarkers, including EV-TF. Subsequently, these patients will be treated according to the usual practices of the department, following recommendations. Patients who received an injected CT scan between Day 5 and Day 28 will be divided into two groups based on the presence or absence of a pulmonary embolism on imaging. The measured values of EV-TF levels and other studied biomarkers will be compared between these two groups in order to detect a possible association between them and the diagnosis of pulmonary embolism. It should be noted that patients receiving an injected CT-scan between Day 5 and Day 7 will be included in the main analysis while those receiving it between Day 8 and Day 28 will be included in the secondary analysis. Others will be excluded from any analysis. At the same time, several collections of clinical data will be carried out: on Day 1, Day 7, Day 28, and on the day of the CT scan if it is performed at another time.

Conditions

Interventions

TypeNameDescription
OTHERBlood sampleAdditional blood samples will be taken on a catheter, used for standard care.

Timeline

Start date
2023-10-31
Primary completion
2027-10-30
Completion
2027-10-30
First posted
2023-05-11
Last updated
2026-02-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05855317. Inclusion in this directory is not an endorsement.